Upstream Bio (UPB) Payables: 2023-2025
Historic Payables for Upstream Bio (UPB) over the last 1 years, with Sep 2025 value amounting to $4.0 million.
- Upstream Bio's Payables fell 19.33% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.3 million, marking a year-over-year change of. This contributed to the annual value of $4.0 million for FY2024, which is 103.07% up from last year.
- Per Upstream Bio's latest filing, its Payables stood at $4.0 million for Q3 2025, which was up 54.92% from $2.6 million recorded in Q2 2025.
- Upstream Bio's Payables' 5-year high stood at $4.9 million during Q3 2024, with a 5-year trough of $2.0 million in Q4 2023.
- In the last 3 years, Upstream Bio's Payables had a median value of $4.0 million in 2024 and averaged $3.7 million.
- As far as peak fluctuations go, Upstream Bio's Payables skyrocketed by 103.07% in 2024, and later fell by 19.33% in 2025.
- Upstream Bio's Payables (Quarterly) stood at $2.0 million in 2023, then soared by 103.07% to $4.0 million in 2024, then declined by 19.33% to $4.0 million in 2025.
- Its Payables was $4.0 million in Q3 2025, compared to $2.6 million in Q2 2025 and $4.7 million in Q1 2025.